Effect of a novel anti-PD-1-proIL-2 bifunctional fusion protein on potent anti-tumor activity via PD-1 checkpoint inhibition and conditional IL-2R agonism. Prediction of immune-related adverse events ...
Asymptotically optimal sequential procedures are developed for point and interval estimation of the difference and ratio of the means of two exponential populations. This is done in a clinical trial ...
Improvements in myeloma specific survival over the last two decades. This is an ASCO Meeting Abstract from the 2022 ASCO Annual Meeting I. This abstract does not include a full text component.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback